WellCare Health Plans, Inc. (NYSE:WCG): stock price is settled at $217.9 after close of last trade. Taking a look at the daily price change trend and size of price movement it is recorded that WCG spotted a negative behavior with drift of -0.24%. WellCare Health Plans, Inc. (WCG) negotiated the trading capacity of 178781 shares and observing the average volume of last three months the stock traded 331.5K shares. The Stock has market cap of $9766.28M and relative volume of 0.54.
WellCare Health Plans, Inc. (WCG) stock has been separated 12.36% away from the 200-day MA. Tracking current stock price levels in relation to some other popular moving averages, we have noted that the stock is trading 7.28% away from the 50-day MA and 1.40% off of the 20-day MA. Checking on recent price levels compared to prior highs and lows, we have seen that WellCare Health Plans, Inc. (WCG) recently traded -1.10% away from the 50-day high and moved 15.71% from the 50-day low. Taking a wider observation, the current separation from the one year high is -1.74%, and the distance from the one year low is presently 34.30%.
WellCare Health Plans, Inc. (NYSE:WCG) reported that Amy Compton-Phillips, M.D., executive vice president and chief clinical officer of Providence St. Joseph Health, and Kathleen E. Walsh, president and chief executive officer of Boston Medical Center, have been elected to the company’s board of directors.
“We’re thrilled to welcome Dr. Compton-Phillips and Ms. Walsh to our board,” said Chris Michalik, WellCare’s chairman of the board. “From Dr. Compton-Phillips’ clinical experience to Ms. Walsh’s background in hospital administration, both women bring strong leadership skills, experience in partnering with providers, and a deep understanding of our nation’s hospitals and health systems—all of which will be invaluable in supporting WellCare’s focus on providing access to high-quality care and services to our more than 4.3 million members across the country.”
Dr. Compton-Phillips has served as executive vice president and chief clinical officer at Providence St. Joseph Health since 2015. Previously, she served as chief quality officer at The Permanente Federation (part of Kaiser Permanente). Dr. Compton-Phillips joined Kaiser Permanente in 1993 and held a variety of roles including internal medicine service chief, physician director of the Columbia, Maryland geographic region, physician director for population care and guideline director. Dr. Compton-Phillips serves on the board of Multiscale Health Networks, a joint venture between Providence St. Joseph Health and the Institute for Systems Biology to provide healthcare technology solutions. Dr. Compton-Phillips is a board-certified internist. She received her B.S. in biology from Johns Hopkins University and her medical degree from the University of Maryland School of Medicine.
The stock dispatched 13.46% performance during the quarter and performance arrived at 7.50% over the last six months. In the last month, the price performed 4.79%. Shares are now at 26.63% over the past year and year to date performance pointed at 8.35%. Contracting the focus on performance, delivered a move of -0.14% over the last week.
The stock has a beta of 0.92 compared to a beta of 1 for the market, which implies that the stock’s price movements are less extreme than the market as a whole. The stock therefore has below average level of market risk. During the past week, the stock’s average weekly volatility was 1.08% and 1.99% volatility over the past 30 days.
Category – Business
Brandon Debolt has an experience in Content Writing, Journalism and love writing stories full of efficient language and accurate content. He is a graduate of University of Sydney and has two years’ experience of Wall Street Investor. Brandon covers Business category. His articles are published on Seeking Alpha, The Street, and The Motley Fool. Brianna has over 4 year experience as a news writer. Previously, he worked as a tech news reporter.
Email Contact: Brandon@thenewsbloom.org